CYP2J2∗7 Genotype Predicts Risk of Chemotherapy-Induced Hematologic Toxicity and Reduced Relative Dose Intensity in Ethiopian Breast Cancer Patients

• Автори: Jemal Hussien Ahmed (Автор), Eyasu Makonnen (Автор), Getnet Yimer (Автор), Daniel Seifu (Автор), Abebe Bekele (Автор), Mathewos Assefa (Автор), Abraham Aseffa (Автор), Rawleigh Howe (Автор), Alan Fotoohi (Автор), Moustapha Hassan (Автор), Eleni Aklillu (Автор)
• Формат: Книга
• Опубліковано: Frontiers Media S.A., 2019-05-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

Chemotherapy-induced hematologic toxicity is the primary reasons of dose reductions and/or delays, low relative dose intensity (RDI), and predicts anticancer response. We investigated the incidence and predictors of chemotherapy-induced hematologic toxicities and reduced RDI in Ethiopian breast canc...